RT @Cognizant_Minds: “Prophylactic antibiotics showed no significant effect on the secondary outcomes of frequency of hospital admissions,…
RT @Cognizant_Minds: “Prophylactic antibiotics showed no significant effect on the secondary outcomes of frequency of hospital admissions,…
“Prophylactic antibiotics showed no significant effect on the secondary outcomes of frequency of hospital admissions, change in forced expiratory volume in one second (FEV1), serious adverse events or all-cause mortality (moderate-quality evidence).” https
@pharma_QD In addition, looking at systematic analyses - the prophylactic use of macrolides (among others) appears to be beneficial in reducing COPD exerbations - albeit with some caveats, i.e. some adverse effects and potentially antimicrobial resistance
抗菌薬の予防投与について COPD Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD) - Herath, SC - 2018 | Cochrane Library https://t.co/jLJmelBQ3Z
@1EEX303 @dean_a_1984 What are you talking about? Just making shit up? https://t.co/UOFerjYz0h
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD) https://t.co/HIdiiiGSXl
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD) - Herath, SC - 2018 | Cochrane Library https://t.co/mKa5KvfcMx
RT @XBayona: "Use of continuous and intermittent prophylactic antibiotics results in a clinically significant benefit in reducing exacerbat…
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD) - Herath, SC - 2018 | Cochrane Library https://t.co/BpxTnIWaFc
RT @XBayona: "Use of continuous and intermittent prophylactic antibiotics results in a clinically significant benefit in reducing exacerbat…
RT @XBayona: "Use of continuous and intermittent prophylactic antibiotics results in a clinically significant benefit in reducing exacerbat…
RT @XBayona: "Use of continuous and intermittent prophylactic antibiotics results in a clinically significant benefit in reducing exacerbat…
"Use of continuous and intermittent prophylactic antibiotics results in a clinically significant benefit in reducing exacerbations in COPD patients. All studies of continuous and intermittent antibiotics used macrolides" https://t.co/rQLtq55BA8
RT @reesprescribe: SR of 14 RCTs reports fewer exacerb for COPD pts with use of continuous or intermittent prophylactic abx. Benefit must b…
RT @reesprescribe: SR of 14 RCTs reports fewer exacerb for COPD pts with use of continuous or intermittent prophylactic abx. Benefit must b…
SR of 14 RCTs reports fewer exacerb for COPD pts with use of continuous or intermittent prophylactic abx. Benefit must be weighed against ADRs (some major eg hearing loss re azithro) & contrib to individual/ community abx resistance #prescribing https:
RT @docteurniide: Poke @DocArnica à faire lire au médecin conseil qui t'a envoyé un courrier à ce sujet https://t.co/aa2IGh9cGF
Poke @DocArnica à faire lire au médecin conseil qui t'a envoyé un courrier à ce sujet https://t.co/aa2IGh9cGF
Antibioprophylaxie pour les patients atteints de BPCO https://t.co/5hnzeuiLFr
RT @rincondesisifo: (Cochrane) Profilaxis antibiótica de las exacerbaciones de la EPOC https://t.co/nMEx6U9gDG https://t.co/StdH8PAspI
RT @rincondesisifo: (Cochrane) Profilaxis antibiótica de las exacerbaciones de la EPOC https://t.co/nMEx6U9gDG https://t.co/StdH8PAspI
RT @rincondesisifo: (Cochrane) Profilaxis antibiótica de las exacerbaciones de la EPOC https://t.co/nMEx6U9gDG https://t.co/StdH8PAspI
(Cochrane) Profilaxis antibiótica de las exacerbaciones de la EPOC https://t.co/nMEx6U9gDG https://t.co/StdH8PAspI
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @VinceMak2: Evidence to support use of prophylactic low dose macrolides in moderate-severe COPD with frequent exacerbations. However, tr…
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @Farma_Ciencia: El tratamiento profiláctico con antibióticos útil para prevenir las exacerbaciones en EPOC. https://t.co/Fy0Doapk8c
RT @Farma_Ciencia: El tratamiento profiláctico con antibióticos útil para prevenir las exacerbaciones en EPOC. https://t.co/Fy0Doapk8c
@DocArnica il semblerait que le bénef sur le nbre d'hospi ne soit pas si probant, juste sur le nbre d'exarcerbat°, au prix du risque d'antibiorésistance et d'EI auditifs (et prière pour ma paroisse, préciser si possible le hors AMM au pharma ainsi que le c
RT @Farma_Ciencia: El tratamiento profiláctico con antibióticos útil para prevenir las exacerbaciones en EPOC. https://t.co/Fy0Doapk8c
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @Farma_Ciencia: El tratamiento profiláctico con antibióticos útil para prevenir las exacerbaciones en EPOC. https://t.co/Fy0Doapk8c
RT @Farma_Ciencia: El tratamiento profiláctico con antibióticos útil para prevenir las exacerbaciones en EPOC. https://t.co/Fy0Doapk8c
RT @Farma_Ciencia: El tratamiento profiláctico con antibióticos útil para prevenir las exacerbaciones en EPOC. https://t.co/Fy0Doapk8c
RT @Farma_Ciencia: El tratamiento profiláctico con antibióticos útil para prevenir las exacerbaciones en EPOC. https://t.co/Fy0Doapk8c
RT @Farma_Ciencia: El tratamiento profiláctico con antibióticos útil para prevenir las exacerbaciones en EPOC. https://t.co/Fy0Doapk8c
El tratamiento profiláctico con antibióticos útil para prevenir las exacerbaciones en EPOC.
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @alfonso_casi: Tratamiento antibiótico profiláctico para la enfermedad pulmonar obstructiva crónica (EPOC): los antibióticos profiláctic…
Tratamiento antibiótico profiláctico para la enfermedad pulmonar obstructiva crónica (EPOC): los antibióticos profilácticos continuos o intermitentes obtienen beneficios clínicamente significativos en la reducción de las exacerbaciones en algunos pacientes
多分9日目。COPDに対する予防的な抗菌薬。解析に入ってるのはマクライドだけではない。 https://t.co/91vk0o8qp2 https://t.co/l1ubX9RGoa
A helpful publication from @cochranecollab which provides evidence for a vexed question in primary care. Prophylactic antibiotic therapy for COPD. Time for shared care guidance @ENHertsCCG . Thanks @BeckyNormansell et al @CochraneAirways https://t.co/NDXE
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @CochraneUK: Can regular (continuous, intermittent or pulsed) treatment with prophylactic antibiotics reduce exacerbations or improve qu…
RT @dipi1_con: Prophylactic #AntibioticTherapy for chronic obstructive pulmonary disease #COPD https://t.co/OhZIo29PxZ @CochraneLibrary…
Prophylactic #AntibioticTherapy for chronic obstructive pulmonary disease #COPD https://t.co/OhZIo29PxZ @CochraneLibrary #ECM https://t.co/zsgXBghCkl
Interesting findings - food for thought! @kerryhood @DaveGuk87 @nickafrancis
Moxi as COPD prophylaxis - madness, as low barrier to resistance.
Recent (Oct. 30) Cochrane Review eval impact of prophylactic antibiotics (mainly macrolides, doxy, moxi) on rates of #COPD Exacerbation. Results: NNT (3-12 months to prevent 1 exacerbation) = 8. Will this impact your practice? COPD Awareness Month! https:/
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). https://t.co/HheJkJU9yP
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). https://t.co/Wwep4gmtJv
RT @CIDRAP_ASP: .@CochraneAirways published reviews on antibiotic use for acute COPD exacerbations (https://t.co/ldaxRDiViH) and COPD proph…
AUTHORS' CONCLUSIONS: Use of continuous and intermittent prophylactic antibiotics results in a clinically significant benefit in reducing exacerbations in COPD patients. All studies of continuous and intermittent antibiotics used... https://t.co/XrGzOP0qJn
RT @CIDRAP_ASP: .@CochraneAirways published reviews on antibiotic use for acute COPD exacerbations (https://t.co/ldaxRDiViH) and COPD proph…
RT @CochraneAirways: Updated #CochraneEvidence: Prophylactic antibiotic therapy for chronic obstructive pulmonary disease #COPD https://t.c…
.@CochraneAirways published reviews on antibiotic use for acute COPD exacerbations (https://t.co/ldaxRDiViH) and COPD prophylactic therapy (https://t.co/ZfsRgFaXPm), highlighting the need to balance benefits and harms to individuals and populations
RT @CochraneAirways: Updated #CochraneEvidence: Prophylactic antibiotic therapy for chronic obstructive pulmonary disease #COPD https://t.c…
RT @MBResp: Another good Cochrane review. Azithromycin probably over prescribed in my view (as opposed to improving the overall care of pat…
@CopdNaz something for us to look at - I’m just very mindful of side effects in our mod-severe COPD population. Basics need doing right - inhaler technique, PR, smoking cessation first.
RT @CochraneAirways: Updated #CochraneEvidence: Prophylactic antibiotic therapy for chronic obstructive pulmonary disease #COPD https://t.c…
RT @CochraneAirways: Updated #CochraneEvidence: Prophylactic antibiotic therapy for chronic obstructive pulmonary disease #COPD https://t.c…
RT @PennPulmonary: High quality meta-analysis showing prophylactic antibitotics for patients with COPD reduced rate of yearly exacerbations…
High quality meta-analysis showing prophylactic antibitotics for patients with COPD reduced rate of yearly exacerbations (rate ratio 0.67, .54-.83) and reduced number of patients with 1+ exacerbations (OR 0.57, 0.42-78 --> NNT 8).
Monitoring of significant side effects including hearing loss, tinnitus, and long QTc in the community in this elderly patient group may require extra health resources [4/4] https://t.co/v7FE7TLdce